Global Automated Suturing Devices Market Overview:
Sutures are used to close wounds and treat damage with surgical sutures. Ophthalmology, orthopaedics, gynaecology, cardiovascular surgery, orthopaedic surgery, and laparoscopy are just a few of the uses for these instruments. Surgical suture devices can be operated manually or automatically. Suture needles are mostly used to close surgical wounds. Disposable or reusable automated suture devices are available. The increase in the number of operations, as well as the number of accidents and trauma cases, are two important factors contributing to the market's growth.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Technology Advancement in Surgical Devices
Market Growth Drivers:
Increased Number of Surgical Procedures and Rise in Accidents and Trauma Cases
Challenges:
Lack of Skilled Professionals
Restraints:
High Cost of the Devices
Opportunities:
Increase in the Medical Tourism Industry and Growth in Favorable Reimbursement Scenario
Competitive Landscape:
The companies are determining this industry across new geographical areas by accepting numerous strategic growth areas such as mergers & acquisitions, expansions, investments, new product launches, and others. The market key players are exploring new areas through growths and achievements across the globe to benefit from competitive advantage through combined synergies
Some of the key players profiled in the report are Ethicon, Inc. (United States), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith& Nephew plc (United Kingdom), Boston Scientific Corporation (United States), DemeTECH Corporation (United States), EndoEvolution, LLC. (United States), Apollo Endosurgery, Inc. (United States), Surgical Specialties Corporation (United States) and Mellon Medical B.V. (Netherlands). Analyst at AMA Research see United States Players to retain maximum share of Global Automated Suturing Devices market by 2028. Considering Market by End User, the sub-segment i.e. Hospitals & Clinics will boost the Automated Suturing Devices market.
Latest Market Insights:
In Sept 2019, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.
In Dec 2019, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.
What Can be Explored with the Automated Suturing Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Automated Suturing Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Automated Suturing Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Automated Suturing Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Automated Suturing Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Automated Suturing Devices Manufacturers and Suppliers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.